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Introduction 
Active secretion by kidney transporters largely contributes to the elimination
of drugs that are substrates for these transporters, however, there is limited
information regarding the maturation of their expression and activity
throughout the paediatric age-range [1]. This information could lead to more
accurate clearance (CL) predictions for drugs that are renally actively
secreted and, ultimately, to improved paediatric drug development.
Conclusion
• We used a combined popPK and PBPK approach on clinical data to quantify the in vivo maturation for active tubular secretion for a broad paediatric 
age-range. This method could be extended to drugs that are substrates for other kidney transporters.
• As direct measurements to quantifying transporters proteins levels throughout the pediatric age-range remains demanding, the presented method 
is a potential alternative to derive kidney transporters maturation. 
• The estimated maturation function for kidney OATs could be used for CL extrapolations of other OAT substrates from adults to children.
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Individual intrinsic clearance values (orange) of amoxicillin and maturation function of OATs






Contribution of CL through GFR (grey) and through ATS (orange) to total renal CL of
amoxicillin for each individual pediatric patient.





Characterize the maturation of the organic anion transporters
1 and 3 system (OATs) throughout the paediatric age range
using clinical PK data from children aged 1 month to 15 years
receiving simultaneously clavulanic acid (cleared by
glomerular filtration (GF) [2]) and amoxicillin (cleared by GF
and active tubular secretion [3]) analysed in a combined
population PK and PBPK approach.
Methods
Results
• The maturation profile for OAT transporters (i.e., CLint,OAT,i) is best described by a sigmoid Emax relationship on the basis of PMA as a covariate
(Figure 1).
• The mature CLint,OAT,p value is 31 ml/h/g kidney (RSE% of 17%).
• Half of the mature Clint,OAT,p value (θTM50) is reached at PMA of 74.9 weeks (~8 months) (RSE% of 9%).
• Figure 2 shows the total renal CL of amoxicillin (CLAmoxicillin,i) where:
• The contribution of GFR changes with cBW , PMA and the estimated individual correction factor θi (Figure 2).
• The median contribution of active tubular secretion is 29% (range: 11% -47%) (Figure 2).
• The individual correction factor for GFR (θi) of intensive care children is 2.04 (RSE% of 8%).
